PTEN and neoplasm: For example, the over expression of miR-221 in hepatocellular carcinoma exerts an oncogenic function by downregulating the expression of PTEN, but in erythroblastic leukaemia it acts as a tumour suppressor by reducing the expression of the KIT oncogene [15,17].